These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 59233)

  • 1. Letter: Protective activity of whooping-cough convalescent serum and serum-IgA level in mice infected with Bordetella pertussis.
    Pittman M
    Lancet; 1976 Jul; 2(7977):156. PubMed ID: 59233
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective role of maternally derived antibodies against Bordetella pertussis in young infants.
    Heininger U; Riffelmann M; Bär G; Rudin C; von König CH
    Pediatr Infect Dis J; 2013 Jun; 32(6):695-8. PubMed ID: 23429559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive acquisition of protective antibodies reactive with Bordetella pertussis in newborns via placental transfer and breast-feeding.
    Quinello C; Quintilio W; Carneiro-Sampaio M; Palmeira P
    Scand J Immunol; 2010 Jul; 72(1):66-73. PubMed ID: 20591078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Role of Passively Transferred Maternal Cytokines against Bordetella pertussis Infection in Newborn Piglets.
    Elahi S; Thompson DR; Van Kessel J; Babiuk LA; Gerdts V
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28167667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
    Cahill ES; O'Hagan DT; Illum L; Redhead K
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M; Nagai M
    Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory IgA against pertussis toxin and surface structures of Bordetella pertussis in saliva of children with culture proven pertussis.
    Frühwirth M; Wolf H; Heininger H; Guggenbichler JP; Stehr E
    Adv Exp Med Biol; 1995; 371B():777-83. PubMed ID: 7502896
    [No Abstract]   [Full Text] [Related]  

  • 9. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH; Gerdts V
    J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Duration of efficiency of pertussis immunoglobulin in the passive protection tests in mice (author's transl)].
    Sabin S; Schwanig M; Schneider W
    Zentralbl Bakteriol A; 1981; 249(2):254-60. PubMed ID: 6267844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.
    Wolfe DN; Goebel EM; Bjornstad ON; Restif O; Harvill ET
    Infect Immun; 2007 Oct; 75(10):4972-9. PubMed ID: 17698566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the serologic type in experimental immunity against B. Pertussis.
    Pusztai Z; Joó I
    Prog Immunobiol Stand; 1967; 3():309-14. PubMed ID: 4314431
    [No Abstract]   [Full Text] [Related]  

  • 13. Transplacental and transcolostral immunity to pertussis in a mouse model using acellular pertussis vaccine.
    Oda M; Izumiya K; Sato Y; Hirayama M
    J Infect Dis; 1983 Jul; 148(1):138-45. PubMed ID: 6309992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunologic findings in oral pertussis vaccination].
    Kurz R; Mayr J; Höfler KH; Falk W; Rosanelli K
    Padiatr Padol; 1986; 21(1):53-9. PubMed ID: 2870453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory correlates of protection and protective immunity to Bordetella pertussis.
    Shahin RD; Mink C; Wiedermann BL; Meade BD
    Adv Exp Med Biol; 1992; 327():287-92. PubMed ID: 1295347
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunity to pertussis. Not all virulence factors are protective antigens.
    Robbins JB; Schneerson R; Bryla DA; Trollfors B; Taranger J; Lagergård T
    Adv Exp Med Biol; 1998; 452():207-18. PubMed ID: 9889975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis.
    Brodeur BR; Martin D; Hamel J; Shahin RD; Laferrière C
    Springer Semin Immunopathol; 1993; 15(2-3):205-15. PubMed ID: 8256198
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of surface antigens in the protective potency of Bordetella pertussis suspensions as measured by the intracerebral challenge technique in mice.
    Holt LB; Spasojevíc V
    J Med Microbiol; 1968 Aug; 1(1):119-26. PubMed ID: 4318938
    [No Abstract]   [Full Text] [Related]  

  • 20. The antibody activities of 19S and 7S fractions from rabbit antisera to Bordetella pertussis.
    Dolby JM; Dolby DE
    Immunology; 1969 Jun; 16(6):737-47. PubMed ID: 4306784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.